Polygenic hypercholesterolemia is an autosomal dominant familial condition wherein mutation in several small LDL raising alleles leads to an elevation in serum cholesterol levels. The condition is asymptomatic and is usually detected on routine screening. Other causes for increased serum cholesterol include familial hypercholesterolemia, hypercholesterolemia secondary to liver disease, hypothyroidism, nephrotic syndrome, chronic renal disease, hypopituitarism.

While PCP plays an important role in evaluation and treatment, it is important to consult with an inter-professional team of specialists which include cardiologists and geneticists. The pharmacist will ensure whether the patient is on a hypolipidemic agent.

Proper evaluation and treatment will lead to a reduction in TIA, strokes, CAD, and PVD.